ArticleBMC pediatrics2026

Dupilumab efficacy in children aged 6 months to younger than 6 years with moderate-to-severe atopic dermatitis and clinical characteristics of early super-responders.

Li Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.